Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Norfloxacin

An antibiotic of the fluoroquinolone family, discovered in Japan in the late 1970s and approved in the United States in 1986, used mainly for urinary tract infections. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.

Did you know?It descends from nalidixic acid, born as a by-product of the synthesis of the antimalarial chloroquine: adding a single fluorine atom to the quinolone ring greatly broadened its activity, hence the name fluoroquinolones.

NorfloxacinGo to the active ingredient →
NorfloxacinActive ingredientNorfloxacinCat. No. P-N092-001CAS 70458-96-7
Norfloxacin-d5Isotopically labelledNorfloxacin-d5Cat. No. P-N092-018CAS 1015856-57-1
Norfloxacin-d8Isotopically labelledNorfloxacin-d8Cat. No. P-N092-019CAS 1216601-32-9

EDQM standards 4

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.